Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Vienna - Delayed Quote EUR

Sartorius Aktiengesellschaft (SATG.VI)

192.80
+8.00
+(4.33%)
At close: May 2 at 5:32:26 PM GMT+2

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Dr. Joachim Kreuzburg Chairman of Executive Board & CEO 1.44M -- 1965
Dr. Florian Funck Dipl.Kfm. CFO & Member of Executive Board 1.07M -- 1971
Dr. Rene Faber Head of Bioprocess Solutions Division & Member of Executive Board 1.02M -- 1975
Dr. Alexandra Gatzemeyer Head of the Lab Products & Services Division and Member of Executive Board 830k -- 1979
Ms. Petra Kirchhoff Head of Corporate Communications & Investor Relations and Member of Supervisory Board 82k -- 1969
Ms. Patricia Spannagel Head of Quality Assurance - Mechatronics Division Goettingen -- -- --
Ralf Mohrschladt Physicist & Head of Supply Chain Management - Germany -- -- --
Ms. Petra Muller Head of Investor Relations -- -- --
Mr. Maurice Phelan President of Sartorius North America -- -- --
Dr. Theo Thijssen President of Environmental Technology Division -- -- --

Sartorius Aktiengesellschaft

Otto-Brenner-Strasse 20
Göttingen, 37079
Germany
49 551 308 0 https://www.sartorius.com
Sector: 
Healthcare
Full Time Employees: 
13,573

Description

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cytometry; ultrafiltration solutions; syringe, membrane, glass and quartz microfiber, clarification, syringeless, and in-line filters; and lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, and support and services; live-cell imaging and analysis software; contract manufacturing and integration; OEM membranes and devices, weigh cells, and data analytics; connectivity, and pipetting and dispensing products; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and surface plasmon resonance and process filtration products. The company offers water purification systems; lab data and fleet management software; lab balances, pipette calibration, mass comparators and metrology, moisture analyzers, weights and weight sets, paint mixing solutions, and weighing accessories; and bioprocess consulting and engineering, biologics testing, cell culture media, instrument, octet service and support, and validation services. It serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

Corporate Governance

Sartorius Aktiengesellschaft’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

July 22, 2025 at 5:00 AM UTC

Sartorius Aktiengesellschaft Earnings Date

Recent Events

March 28, 2025 at 12:00 AM UTC

Ex-Dividend Date

August 23, 1970 at 12:00 AM UTC

Dividend Date